PT Diagnos Laboratorium Utama Tbk (IDX:DGNS)
Indonesia · Delayed Price · Currency is IDR 268.00
-4.00 (-1.47%)
Apr 29, 2026, 9:18 AM WIB
IDX:DGNS Market Cap
IDX:DGNS has a market cap or net worth of 340 billion as of April 28, 2026. Its market cap has increased by 66.87% in one year.
Market Cap
340.00B
Enterprise Value
407.21B
Revenue
166.62B
Ranking
n/a
PE Ratio
115.76
Stock Price
268.00
Market Cap Chart
Since January 15, 2021, IDX:DGNS's market cap has increased from 337.50B to 340.00B, an increase of 0.74%. That is a compound annual growth rate of 0.14%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Apr 28, 2026 | 340.00B | 47.83% |
| Dec 30, 2025 | 230.00B | -5.64% |
| Dec 30, 2024 | 243.75B | -20.73% |
| Dec 29, 2023 | 307.50B | 0.82% |
| Dec 30, 2022 | 305.00B | -67.25% |
| Dec 30, 2021 | 931.25B | 175.93% |
| Jan 15, 2021 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| PT Sejahteraraya Anugrahjaya Tbk | 182.11T |
| PT Kalbe Farma Tbk. | 40.08T |
| PT Siloam International Hospitals Tbk | 32.99T |
| PT Mitra Keluarga Karyasehat Tbk | 28.37T |
| PT Diastika Biotekindo Tbk | 571.75B |
| PT Maja Agung Latexindo Tbk | 475.08B |
| PT Indofarma Tbk | 390.51B |
| PT Ikapharmindo Putramas Tbk | 340.30B |